Repurposing the angiotensin II receptor blocker valsartan to inhibit penicillin-binding protein 3 and its mutants in Haemophilus influenzae: a comprehensive in silico approach
IntroductionAmpicillin-resistant Haemophilus influenzae (H. influenzae) has been recently designated as a medium-priority bacterial pathogen in 2024 by the World Health Organization (WHO). This pathogen is responsible for a wide range of infections, including sinusitis, acute otitis media, and pneum...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2026-04-01
|
| シリーズ: | Frontiers in Bioinformatics |
| 主題: | |
| オンライン･アクセス: | https://www.frontiersin.org/articles/10.3389/fbinf.2026.1765472/full |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|